David Georges
Director of Finance/CFO bei CELYAD ONCOLOGY SA
Profil
David Georges is currently the Vice President-Finance & Administration at Celyad Oncology SA. Previously, he worked as the Director-Finance & Administration at DIAsource ImmunoAssays SA and as a Financial Manager at Merck KGaA.
Mr. Georges completed his undergraduate degree at Université Catholique de Louvain.
Aktive Positionen von David Georges
| Unternehmen | Position | Beginn |
|---|---|---|
| CELYAD ONCOLOGY SA | Director of Finance/CFO | 01.01.2019 |
Ehemalige bekannte Positionen von David Georges
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | - |
DIAsource ImmunoAssays SA
 DIAsource ImmunoAssays SA BiotechnologyHealth Technology DIAsource ImmunoAssays SA manufactures and distributes clinical diagnostics products. It develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The firm offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping customers to automate their tests. The company was founded in 1996 and is headquartered in Louvain-la-Neuve, Belgium. | Director of Finance/CFO | - |
Ausbildung von David Georges
| Université Catholique de Louvain | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| CELYAD ONCOLOGY SA | Health Technology |
| Private Unternehmen | 1 |
|---|---|
DIAsource ImmunoAssays SA
DIAsource ImmunoAssays SA BiotechnologyHealth Technology DIAsource ImmunoAssays SA manufactures and distributes clinical diagnostics products. It develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The firm offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping customers to automate their tests. The company was founded in 1996 and is headquartered in Louvain-la-Neuve, Belgium. | Health Technology |
